Suppr超能文献

SarQoL 问卷的反应度评估,这是一种专门针对肌肉减少症的患者报告结局测量工具。

Evaluation of the Responsiveness of the SarQoL Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia.

机构信息

Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.

出版信息

Adv Ther. 2018 Nov;35(11):1842-1858. doi: 10.1007/s12325-018-0820-z. Epub 2018 Oct 29.

Abstract

INTRODUCTION

The Sarcopenia Quality of Life (SarQoL) questionnaire was developed to provide a patient-reported outcome measure specific to sarcopenia. Its psychometric properties indicate that it is a valid and reliable instrument. However, until now, its ability to detect change over time has not been examined. Therefore, the objective of this study is to evaluate the responsiveness (also known as sensitivity to change) of the SarQoL questionnaire in a prospective, longitudinal cohort of community-dwelling, older, sarcopenic subjects.

METHODS

Sarcopenic subjects from the SarcoPhAge (Sarcopenia and Physical impairment with advancing Age) study were included. Responsiveness was evaluated with nine pre-specified hypotheses on the correlation between the evolution of the SarQoL scores after a 2-year interval and the evolution of the scores on the Short Form-36 (SF-36) and the Euroqol 5-dimension (EQ-5D) questionnaires. This technique considers responsiveness to be a form of longitudinal validity. Additionally, standardized response means were also calculated to compare the quantity of change measured by the different questionnaires.

RESULTS

A total of 42 sarcopenic subjects were included. The median age of the sample was 72.9 (68.9-78.8) years, 59.5% were female, and the mean body mass index was 23.3 (20.4-25.7) kg/m. A good responsiveness was observed, as evidenced by the confirmation of eight out of nine hypotheses, well above the 75% confirmation threshold. The standardized response mean of the Overall SarQoL score was significantly higher than those of the SF-36 Physical Component Summary (p = 0.005), the EQ-5D Utility Index (p < 0.001) and the Euroqol visual analogue scale (p = 0.003).

CONCLUSION

The first data available on the ability of the SarQoL questionnaire to detect change over time indicates that the questionnaire has good responsiveness. This, together with the previously established psychometric properties, confirms that the SarQoL questionnaire is a relevant instrument for the assessment of quality of life in sarcopenic populations.

摘要

简介

肌肉减少症生活质量(SarQoL)问卷是为提供专门针对肌肉减少症的患者报告结局测量工具而开发的。其心理测量学特性表明,它是一种有效且可靠的工具。然而,到目前为止,其随时间变化的检测能力尚未得到检验。因此,本研究的目的是评估 SarQoL 问卷在社区居住的、年龄较大的、患有肌肉减少症的前瞻性纵向队列中的反应能力(也称为对变化的敏感性)。

方法

纳入 SarcoPhAge(肌肉减少症和身体损伤与年龄增长)研究中的肌肉减少症受试者。通过九个预设假设来评估反应能力,这些假设是基于两年间隔后 SarQoL 评分的变化与短期表格 36(SF-36)和欧洲五维健康量表(EQ-5D)评分的变化之间的相关性。这种技术将反应能力视为一种纵向有效性。此外,还计算了标准化反应均值,以比较不同问卷测量的变化量。

结果

共纳入 42 名肌肉减少症受试者。样本的中位年龄为 72.9(68.9-78.8)岁,59.5%为女性,平均体重指数为 23.3(20.4-25.7)kg/m。观察到良好的反应能力,有九个假设中的八个得到证实,远高于 75%的确认阈值。总体 SarQoL 评分的标准化反应均值明显高于 SF-36 生理成分综合评分(p=0.005)、EQ-5D 效用指数(p<0.001)和欧洲五维健康量表视觉模拟评分(p=0.003)。

结论

SarQoL 问卷检测随时间变化能力的首批数据表明,该问卷具有良好的反应能力。这与之前建立的心理测量学特性一起,证实了 SarQoL 问卷是评估肌肉减少症人群生活质量的一个相关工具。

相似文献

1
Evaluation of the Responsiveness of the SarQoL Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia.
Adv Ther. 2018 Nov;35(11):1842-1858. doi: 10.1007/s12325-018-0820-z. Epub 2018 Oct 29.
2
Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia.
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):238-244. doi: 10.1002/jcsm.12149. Epub 2016 Oct 22.
4
5
Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL questionnaire.
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):319-330. doi: 10.1002/jcsm.12687. Epub 2021 Feb 28.
6
Validation of the Persian version of the sarcopenia-specific quality of life questionnaire (SarQoL-IR).
Aging Clin Exp Res. 2023 Jan;35(1):137-145. doi: 10.1007/s40520-022-02255-0. Epub 2022 Oct 26.
7
Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire.
Disabil Rehabil. 2020 Apr;42(7):1006-1012. doi: 10.1080/09638288.2018.1514076. Epub 2018 Nov 19.
8
Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL).
BMC Musculoskelet Disord. 2023 Jun 2;24(1):445. doi: 10.1186/s12891-023-06559-8.

引用本文的文献

2
Patient-reported outcomes in sarcopenia: An ICFSR task force report.
J Frailty Aging. 2025 Feb;14(1):100010. doi: 10.1016/j.tjfa.2024.100010. Epub 2025 Jan 1.
3
Probiotics Supplements Improve the Sarcopenia-Related Quality of Life in Older Adults with Age-Related Muscle Decline.
Calcif Tissue Int. 2024 Jun;114(6):583-591. doi: 10.1007/s00223-024-01211-6. Epub 2024 Apr 20.
5
Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women.
Aging Clin Exp Res. 2023 Oct;35(10):2069-2079. doi: 10.1007/s40520-023-02488-7. Epub 2023 Jul 13.
6
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.
Aging Clin Exp Res. 2023 Aug;35(8):1581-1593. doi: 10.1007/s40520-023-02438-3. Epub 2023 May 23.
7
Sarcopenia and health-related quality of life: A systematic review and meta-analysis.
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1228-1243. doi: 10.1002/jcsm.13243. Epub 2023 May 4.
8
Markers for the Prediction of Probably Sarcopenia in Middle-Aged Individuals.
J Pers Med. 2022 Nov 3;12(11):1830. doi: 10.3390/jpm12111830.
9
Pre-sarcopenia is associated with health-related quality of life in patients with primary Sjögren's syndrome.
Clin Rheumatol. 2023 Mar;42(3):783-791. doi: 10.1007/s10067-022-06427-1. Epub 2022 Nov 11.

本文引用的文献

2
Bone health assessment in older people with or without muscle health impairment.
Osteoporos Int. 2018 May;29(5):1057-1067. doi: 10.1007/s00198-018-4384-1. Epub 2018 Feb 14.
3
Pitfalls in the measurement of muscle mass: a need for a reference standard.
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):269-278. doi: 10.1002/jcsm.12268. Epub 2018 Jan 19.
5
Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia.
Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):335-341. doi: 10.1080/14737167.2017.1360768.
8
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis.
PLoS One. 2017 Jan 17;12(1):e0169548. doi: 10.1371/journal.pone.0169548. eCollection 2017.
9
Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia.
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):238-244. doi: 10.1002/jcsm.12149. Epub 2016 Oct 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验